Tympanogen key facts
as of Oct 2026- Developer of medical devices for ear, nose, and throat (ENT) designed to replace traditional surgical procedures with clinic visits.
- Tympanogen is valued at approximately $20.6M as of Oct 2026, set at its later-stage round, Dec 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $6.0M across 2 recorded rounds; the latest was Seed Round ($1.2M) in Feb 2025.
- Notable investors include MedTech Innovator, United States Department of War, Keiretsu Forum, Virginia Innovation Partnership Corporation, Virginia Venture Partners — 27 tracked in total.
- Tympanogen has filed 3 Form Ds with the SEC since 2022, most recently Mar 2025 ($1.2M sold to 33 investors).
- Status: Privately Held (backing).
Valued at $20.6M at its later-stage round, Dec 2025. Nothing has traded since.
- ·The complete investor list: 27 names
- ·Watch Tympanogen: the Monday email on marks, rounds and moves
Tympanogen funding rounds
2 roundsWho backs Tympanogen
27+Membership and data by Private Market View
Tympanogen valuation
Tympanogen was valued at $20.6 million at its later-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Tympanogen raised?
Tympanogen has raised $6 million in total; 2 of its rounds are on record. The largest on record was a $1.2 million seed round in Feb 2025.
Tympanogen has filed 3 Form Ds with the SEC since 2022, most recently in Mar 2025 ($1.2 million sold to 33 investors).
Tympanogen investors
27 investors are on record for Tympanogen, including MedTech Innovator, United States Department of War, Keiretsu Forum and Virginia Innovation Partnership Corporation. The seed round in Feb 2025 drew 33 investors.
About Tympanogen
Developer of medical devices for ear, nose, and throat (ENT) designed to replace traditional surgical procedures with clinic visits. The company's devices include wound-healing therapies that replace traditional surgical repair of eardrum perforations while decreasing healthcare costs by using technology, enabling surgeons to simplify existing surgical procedures and improve treatment outcomes.
- Sector
- Healthcare
- HQ
- Richmond, VA, United States
- Founded
- 2014
- Employees
- 10
- Website
- tympanogen.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.